BACKGROUND OF THE INVENTION Field of the Invention (Technical Field): The present invention relates to a method and multiple agents for treatment of sexual dysfunction, including male erectile dysfunction, including separate and preferably sequential administration of a melanocortin 3 and/or 4 receptor agonist, such as Ac-Nle-cyc/o(-Asp-His-D-Phe- Arg-Trp-Lys)-OH (PT-141), preferably by one route of administration, such as intranasal (IN), and a type V phosphodiesterase (PDE-5) inhibitor, such as Viagra , a trademark for a brand of sildenafil, preferably by another route of administration, such as oral
Anazco D, Fansa S, Hurtado MD, et al
Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, et al
I work with women on GLP-1 medications, women coming off them, and women who have never used one